Trials / Completed
CompletedNCT05549401
Clinical Trial to Evaluate the Tolerability and the Pharmacokinetics of CKD-348
A Phase I Clinical Trial to Evaluate the Tolerability and the Pharmacokinetics of CKD-348 With Co-administration of CKD-828, D097, and D337 in Healthy Adult Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- Chong Kun Dang Pharmaceutical · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
A phase I clinical trial to evaluate the tolerability and the pharmacokinetics of CKD-348.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CKD-348(4) F1 | QD, PQ |
| DRUG | CKD-348(4) F2 | QD, PQ |
| DRUG | CKD-828, D097, D337 | QD, PQ |
Timeline
- Start date
- 2022-09-29
- Primary completion
- 2022-11-30
- Completion
- 2022-12-09
- First posted
- 2022-09-22
- Last updated
- 2023-06-09
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05549401. Inclusion in this directory is not an endorsement.